Structure data PDB-6c5m : Structure viewer Structure of glycolipid aGSA[8,9] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 2.45 Å
PDB-6c69 : Structure viewer Structure of glycolipid aGSA[12,6P] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 1.937 Å
PDB-6c6a : Structure viewer Structure of glycolipid aGSA[16,6P] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 2.45 Å
PDB-6c6c : Structure viewer Structure of glycolipid aGSA[20,6P] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 2.08 Å
PDB-6c6e : Structure viewer Structure of glycolipid aGSA[26,6P] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 2.18 Å
PDB-6c6h : Structure viewer Structure of glycolipid aGSA[8,P5m] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 2 Å
PDB-6c6j : Structure viewer Structure of glycolipid aGSA[8,P5p] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 1.79 Å
PDB-6cw6 : Structure viewer Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.85 Å
PDB-6cw9 : Structure viewer Structure of alpha-GC[8,16P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2 Å
PDB-6cwb : Structure viewer Structure of alpha-GSA[8,4P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.85 Å
PDB-6cx5 : Structure viewer Structure of alpha-GSA[8,8P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.4 Å
PDB-6cx7 : Structure viewer Structure of alpha-GSA[12,6P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.6 Å
PDB-6cx9 : Structure viewer Structure of alpha-GSA[16,6P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.36 Å
PDB-6cxa : Structure viewer Structure of alpha-GSA[20,6P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.65 Å
PDB-6cxe : Structure viewer Structure of alpha-GSA[26,6P] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.05 Å
PDB-6cxf : Structure viewer Structure of alpha-GSA[26,P5p] bound by CD1d and in complex with the Va14Vb8.2 TCRMethod : X-RAY DIFFRACTION / Resolution : 2.5 Å
PDB-6ojp : Structure viewer Structure of glycolipid alpha-GSA[8,6P] in complex with mouse CD1dMethod : X-RAY DIFFRACTION / Resolution : 2.17 Å
Chemicals ChemComp-NAG : Structure viewer 2-acetamido-2-deoxy-beta-D-glucopyranose
ChemComp-J81 : Structure viewer (5R,6S,7S)-5,6-dihydroxy-N-nonyl-7-(octanoylamino)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)
ChemComp-ELM : Structure viewer N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetra
ChemComp-EL7 : Structure viewer N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]heptadecanamide (non-preferred name)
ChemComp-EMG : Structure viewer N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]icosanamide
ChemComp-EM4 : Structure viewer N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]hexacosanamide
ChemComp-ELG : Structure viewer (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(3-pentylphenyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)te
ChemComp-J76 : Structure viewer (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(4-pentylphenyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)te
ChemComp-PBS : Structure viewer (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL
ChemComp-7LM : Structure viewer N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxy-16-phenylhexadecan-2-yl]octanamide
ChemComp-FJJ : Structure viewer (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-[(1E)-4-phenylbutylidene]-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)
ChemComp-FJM : Structure viewer (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(8-phenyloctyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide (non-preferred name)
ChemComp-ELS : Structure viewer N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(4-pentylphenyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetr
ChemComp-7LP : Structure viewer (5R,6S,7S)-5,6-dihydroxy-7-(octanoylamino)-N-(6-phenylhexyl)-8-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octanamide